Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients.
Relay Therapeutics stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Relay Therapeutics balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Relay Therapeutics cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Relay Therapeutics multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Relay Therapeutics profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Relay Therapeutics assets
Relay Therapeutics cash flows

Relay Therapeutics shares

TickerNameTypeNominal valueISINPrice
RLAY:USRelay TherapeuticCommon share-US75943R1023$6.8
Relay Therapeutics news
06.05.2022
Relay Therapeutics' GAAP loss for 3 months of 2022 was $62.046 million, up 47.1% from $42.184 million in the prior year. Revenue declined 2.3 times to $419,000 from $952,000 a year earlier.
Source: {source} pictogram ir.relaytx.com
Pictogram next
25.02.2022
Relay Therapeutics' GAAP loss for 2021 was $363.872 million, up 6.9 times from $52.412 million in the previous year. Revenue declined 27.7 times to $3.029 million from $82.654 million a year earlier.
Source: {source} pictogram ir.relaytx.com
Pictogram next
11.11.2021
Relay Therapeutics' GAAP loss for 9M 2021 was $296.416 million, up 3.4 times from $87.688 million in the prior year. Revenue was $2,462 million. The company did not generate revenue a year earlier.
Source: {source} pictogram ir.relaytx.com
Pictogram next
13.08.2021
Relay Therapeutics' GAAP loss for 6M 2021 was $235.582 million, up 4.5 times from $51.61 million in the previous year. Revenue was $1.796 million. The company had not generated revenue a year earlier.
Source: {source} pictogram ir.relaytx.com
Pictogram next
All Relay Therapeutics news
General information
Company nameRelay Therapeutics
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address399 Binney Street 2nd Floor Cambridge, MA 02139 United States
Websiteir.relaytx.com
Information disclosurewww.sec.gov